An estimate of missed pediatric sepsis in the emergency department

Christina L Cifra1, Erik Westlund2, Patrick Ten Eyck3

  • 1University of Iowa Carver College of Medicine, Iowa City, USA.

Insights

Approximately 8.1% of pediatric severe sepsis cases in US emergency departments (EDs) may have been missed during prior treat-and-release visits. Factors like fewer chronic conditions and specific states were associated with missed pediatric sepsis diagnoses.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Diseases
  • Health Services Research

Background:

  • Timely diagnosis of pediatric sepsis is a significant clinical challenge.
  • Pediatric sepsis remains a leading cause of preventable mortality and morbidity.
  • Identifying missed sepsis cases in emergency departments (EDs) is crucial for improving outcomes.

Purpose of the Study:

  • To estimate the incidence of potentially missed pediatric sepsis in US emergency departments.
  • To identify factors associated with potentially missed sepsis cases.

Main Methods:

  • Retrospective study using linked inpatient and ED administrative data from four US states.
  • Identified children admitted with severe sepsis/septic shock with a prior ED treat-and-release visit within 7 days.
  • Expert panel reviewed cases; multivariable regression analyzed associations with missed sepsis.

Main Results:

  • Of 1945 severe sepsis/septic shock admissions, 158 (8.1%) had potentially missed sepsis in a prior ED visit.
  • Increased comorbid chronic conditions were associated with lower odds of missed sepsis (OR, 0.86).
  • Higher odds of missed sepsis were observed in California, Florida, and Massachusetts compared to New York.

Conclusions:

  • Administrative data can effectively screen large populations for potential missed sepsis.
  • This approach aids in identifying cases requiring further detailed medical record review.
  • Improving sepsis recognition in EDs is essential for pediatric patient safety.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
153
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
220
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
183